Introduction {#section1-1933719118820469}
============

Endometriosis is a common disease characterized by the growth of endometrial tissue (which normally lines the uterus) outside the uterine cavity.^[@bibr1-1933719118820469]^ The estimated prevalence of endometriosis in women of reproductive age is 2% to 11% in Europe and the United States^[@bibr2-1933719118820469],[@bibr3-1933719118820469]^ and 12% in China.^[@bibr4-1933719118820469]^ The symptoms of endometriosis vary among patients and disease extent^[@bibr5-1933719118820469]^ but usually include painful periods (dysmenorrhea), chronic pelvic pain, pain with intercourse (dyspareunia), and infertility.^[@bibr1-1933719118820469],[@bibr6-1933719118820469],[@bibr7-1933719118820469]^ Endometriosis exerts a considerable impact on health-related quality of life,^[@bibr8-1933719118820469]^ and the variable presentation often leads to a delay in diagnosis.^[@bibr9-1933719118820469],[@bibr10-1933719118820469]^ Currently, there are no curative treatment strategies for endometriosis other than laparoscopic surgery. Although endometriotic lesions can be removed by conservative surgery, the disease can recur in 30% to 50% of women.^[@bibr11-1933719118820469],[@bibr12-1933719118820469]^

Endometriotic lesions may be characterized into 3 phenotypes based on localization and histology: superficial peritoneal endometriosis (SUP), cystic ovarian endometriosis or endometrioma (OMA), and deep infiltrating endometriosis (DIE).^[@bibr13-1933719118820469][@bibr14-1933719118820469]--[@bibr15-1933719118820469]^ These 3 phenotypes can occur either individually or in combination in the same patient. The pathogenesis of endometriosis remains poorly understood but is thought to involve a variety of mechanisms.^[@bibr16-1933719118820469]^ Indeed, hormonal, inflammatory, immunologic, genetic, epigenetic, and environmental factors have all been reported to be associated with endometriosis.^[@bibr17-1933719118820469][@bibr18-1933719118820469][@bibr19-1933719118820469][@bibr20-1933719118820469][@bibr21-1933719118820469][@bibr22-1933719118820469][@bibr23-1933719118820469][@bibr24-1933719118820469][@bibr25-1933719118820469]--[@bibr26-1933719118820469]^ In addition, some studies have suggested that endometriosis may be related to dietary as well as early-life factors (including exposure to environmental toxic agents).^[@bibr27-1933719118820469][@bibr28-1933719118820469][@bibr29-1933719118820469]--[@bibr30-1933719118820469]^ Nevertheless, the SUP, OMA, and DIE phenotypes of endometriosis may have different origins and pathogenetic mechanisms, and there is only limited information regarding the factors associated with these phenotypes in the Chinese population.

The recently published FEELING (Factors associated with the development of Endometrioma and dEep infiLtratING endometriosis) study was a case--control study of 1008 patients in 3 countries (China, Russia, and France), designed to investigate the clinical, lifestyle, and environmental factors associated with OMA and DIE versus SUP and no endometriosis.^[@bibr31-1933719118820469]^ The FEELING study identified several factors associated with OMA and DIE, including previous use of hormonal treatment for endometriosis, previous surgery for endometriosis, and living or working in a city or by a busy area.^[@bibr31-1933719118820469]^ In addition, substantial differences among regions were noted regarding the diagnosis, symptomatology, and management of endometriosis.^[@bibr31-1933719118820469]^

The aim of the present study was to perform a subgroup analysis of data from women in China who were enrolled in the FEELING study in order to investigate the factors associated with different phenotypes of endometriosis, with a focus for early-life factors.

Methods {#section2-1933719118820469}
=======

Study Design {#section3-1933719118820469}
------------

This is a subgroup analysis of the FEELING study^[@bibr31-1933719118820469]^ for the 546 participants in China enrolled between May 2011 and April 2013 to identify early-life exposure factors associated with OMA and/or DIE. The criteria for inclusion and diagnosis of SUP, OMA, and DIE were described in the FEELING study (NCT01351051).^[@bibr13-1933719118820469][@bibr14-1933719118820469]--[@bibr15-1933719118820469],[@bibr31-1933719118820469]^ The women who underwent gynecological surgery for a benign in the past 3 months were considered for recruitment. Deep infiltrating endometriosis was considered in the presence of endometrial tissue infiltrating beneath the peritoneal surface for \>5 mm^[@bibr15-1933719118820469]^ or when the muscularis was infiltrated.^[@bibr14-1933719118820469]^ The patients were classified according to the more severe lesion (SUP, OMA, and the DIE).^[@bibr13-1933719118820469]^

All patients provided informed written consent before participating in the study. The study was approved by the regional independent ethics committees/institutional review boards and was conducted in accordance with the Declaration of Helsinki.

Assessments {#section4-1933719118820469}
-----------

One case report form and 2 questionnaires were collected from each participant in a face-to-face interview with the investigator at the first postsurgical routine visit. Data regarding symptoms and previous medical history, including endometriosis history, presurgical symptoms, details of surgery for endometriosis, endometriosis status, additional gynecologic and medical history, and family medical history, were obtained retrospectively using an internet-based electronic data capture (EDC) case report form. Information regarding current habits, including environment, dietary habits, and health and mood during the postsurgical visit, was collected prospectively using a participant-completed questionnaire. Finally, an investigator-completed EDC questionnaire was used to obtain extra information regarding their age, gender, years in practice in gynecology, practice site information, number of newly diagnosed patients with endometriosis per year, total number of endometriosis cases followed per year, and number of assisted reproductive technologies for endometriosis per year. No safety evaluations were undertaken as this was a noninterventional study.

Objectives {#section5-1933719118820469}
----------

The main objective of this study was to identify early-life exposure factors associated with OMA and/or DIE. For the purposes of the primary analysis, SUP and non-EM were considered as control cases while OMA and DIE were considered as definite disease. The rationale for this was that the clinical significance of SUP remains unclear, with some authors arguing that it may not represent true endometriotic disease.^[@bibr16-1933719118820469],[@bibr32-1933719118820469],[@bibr33-1933719118820469]^

Statistical Analysis {#section6-1933719118820469}
--------------------

As DIE is the less frequent form of endometriosis, the sample size in the original FEELING study was determined according to DIE^[@bibr31-1933719118820469]^: assuming that the frequency of associated factors in the population is 10% and a dropout rate of 20%, the inclusion of 1008 participants allowed the detection of odds ratios (ORs) ≥2 with a significance level of 5% and a power of 90%.

A descriptive statistical analysis was applied. Continuous data were expressed as means (standard deviation) or medians (quartile, maximum value, and minimum value), as appropriate. Categorical variables were expressed as n (%).

Univariable logistic regression analyses were performed to screen for factors potentially associated with OMA and/or DIE. Subsequently, multivariable regression analysis was carried out using a significance level of 10% for entry of variables into the model and a significance level of 5% to retain variables in the model. The Hosmer-Lemeshow goodness-of-fit test was applied to the final selected model, and ORs with 95% confidence intervals (CIs) were calculated. The ORs were considered significant when their associated CI excluded 1.0. *P* \< .05 was considered statistically significant. Of note, associations with borderline *P* values (*P* = .03-.05) should be interpreted with caution. All statistical analyses were performed using SAS software version 9.1 (SAS Institute Inc, Cary, North Carolina).

Results {#section7-1933719118820469}
=======

Participants {#section8-1933719118820469}
------------

A total of 546 women were enrolled in China, 156 (28.6%) in the non-EM group, 156 (28.6%) in the SUP group, 156 (28.6%) in the OMA group, and 78 (14.3%) in the DIE group. The baseline characteristics of the enrolled participants are presented in [Table 1](#table1-1933719118820469){ref-type="table"}.

###### 

Baseline Characteristics of the Study Participants.^a^

![](10.1177_1933719118820469-table1)

  Characteristic                                   Value
  ------------------------------------------------ ---------------
  Age on visit day (years), mean (range)           31.80 (18-41)
  Body mass index (kg/m^2^), mean (SD)             21.37 (3.27)
  Ethnicity                                        
   Asian                                           546 (100%)
   Other                                           0 (0%)
  Marital status                                   
   Single                                          80 (14.7%)
   Married                                         450 (82.4%)
   Free union^b^                                   14 (2.6%)
   Divorced/separated                              2 (0.4%)
   Widowed                                         0 (0%)
  Educational level^c^                             
   Primary school                                  20 (3.7%)
   High school                                     112 (20.6%)
   Vocational or professional school               59 (10.8%)
   Polytechnic or equivalent (+2 years)            38 (7.0%)
   University or business school (+4 to 5 years)   316 (58.0%)
   Data missing                                    1 (0.2%)
  Smoking status                                   
   Current smoker                                  12 (2.2%)
   Ex-smoker                                       4 (0.7%)
   Never smoked                                    530 (97.1%)
  Endometriosis group                              
   No endometriosis                                156 (18.6%)
   Superficial peritoneal endometriosis            156 (28.6%)
   Endometrioma                                    156 (28.6%)
   Deep infiltrating endometriosis                 78 (14.3%)

^a^ Data presented as n (%) unless otherwise stated.

^b^ A union that lacks any publicly recognized bond.

^c^ N = 546, except N = 545 (data missing for 1 participant).

Univariable Analyses of Factors Associated With OMA and DIE {#section9-1933719118820469}
-----------------------------------------------------------

Clinical, lifestyle, and environmental factors found by univariable analyses to be potentially associated with endometriosis are presented in [Table 2](#table2-1933719118820469){ref-type="table"}. Compared with participants in the non-EM and SUP groups, factors associated with OMA and DIE were noncyclic chronic pelvic pain (OR = 2.30, 95% CI: 1.40-3.78), more severe dysmenorrhea (class 1-4: OR = 2.77, 95% CI: 1.77-4.34; class 5-7: OR = 3.31, 95% CI: 2.00-5.46; class 8-10: OR = 6.96, 95% CI: 4.02-12.07), deep dyspareunia (OR = 3.09, 95% CI: 1.81-5.27), gastrointestinal symptoms during menstruation (OR = 3.40, 95% CI: 2.23-5.19), urinary symptoms during menstruation (OR = 4.34, 95% CI: 1.91-9.85), previous surgical diagnosis of endometriosis (OR = 7.07, 95% CI: 3.10-16.14), previous hormonal treatment of endometriosis (OR = 22.32, 95% CI: 7.97-62.52), previous uterine surgery (OR = 1.57, 95% CI: 1.03-2.39), longer time since menarche (OR = 1.47, 95% CI: 1.06-2.03), more regular menstrual cycle (OR = 0.37, 95% CI: 0.17-0.84), no previous use of a progestin-only oral contraceptive (OR = 0.26, 95% CI: 0.07-0.90), previous pregnancy (OR = 1.42, 95% CI: 1.00-2.02), not having been breastfed (OR = 0.48, 95% CI: 0.26-0.88), endometriosis in a first-degree relative (OR = 4.12, 95% CI: 1.10-15.39), and higher alcohol consumption (OR = 9.83, 95% CI: 1.02-95.06; [Table 2](#table2-1933719118820469){ref-type="table"}).

###### 

Univariable Analysis of the Factors Associated With OMA and DIE.

![](10.1177_1933719118820469-table2)

  Characteristic                                         Non-EM + SUP             OMA + DIE                OR (95% CI)           *P*
  ------------------------------------------------------ ------------------------ ------------------------ --------------------- --------
  Age on visit day (years)                               31.44 (5.38; n = 312)    32.27 (5.07; n = 234)    1.35 (0.98-1.87)^a^   .070
  BMI on visit day (kg/m^2^)                                                                                                     .735
   \<18.5                                                45/312                   41/234                   1.24 (0.76-2.02)      
   18.5-21.9                                             155/312                  114/234                  Reference             
   22.0-24.9                                             74/312                   55/234                   1.01 (0.66-1.55)      
   ≥25.0                                                 38/312                   24/234                   0.86 (0.49-1.51)      
  Weight change \>±5 kg in previous 3 months                                                                                     .758
   Yes                                                   5/312                    3/234                    0.80 (0.19-3.37)      
   No                                                    307/312                  231/234                  Reference             
  Marital status                                                                                                                 .797
   Single                                                50/312                   30/234                   0.78 (0.48-1.27)      
   Married                                               254/312                  196/234                  Reference             
   Free union^b^                                         8/312                    6/234                    0.97 (0.33-2.85)      
   Divorced/separated                                    0/312                    2/234                    --                    
  Education                                                                                                                      .109
   Primary or high school                                87/311                   45/234                   0.61 (0.40-0.93)      
   Vocational or professional school                     34/311                   25/234                   0.87 (0.49-1.52)      
   Polytechnic or equivalent                             19/311                   19/234                   1.18 (0.60-2.31)      
   University or business school                         171/311                  145/234                  Reference             
  Smoking status                                                                                                                 .062
   Current or ex-smoker                                  13/312                   3/234                    0.30 (0.08-1.06)      
   Never smoked                                          299/312                  231/234                  Reference             
  Noncyclic chronic pelvic pain                                                                                                  \<.001
   Yes                                                   30/312                   46/234                   2.30 (1.40-3.78)      
   No                                                    282/312                  188/234                  Reference             
  Dysmenorrhea intensity class                                                                                                   \<.001
   0                                                     177/312                  61/234                   Reference             
   1-4                                                   67/312                   64/234                   2.77 (1.77-4.34)      
   5-7                                                   43/312                   49/234                   3.31 (2.00-5.46)      
   8-10                                                  25/312                   60/234                   6.96 (4.02-12.07)     
  Pain at time of ovulation                                                                                                      .236
   Yes                                                   14/312                   16/234                   1.56 (0.75-3.27)      
   No                                                    298/312                  218/234                  Reference             
  Deep dyspareunia                                                                                                               \<.001
   Yes                                                   23/312                   46/233                   3.09 (1.81-5.27)      
   No                                                    289/312                  187/233                  Reference             
  Infertility                                                                                                                    .179
   Yes                                                   95/312                   59/234                   0.77 (0.53-1.13)      
   No                                                    217/312                  175/234                  Reference             
  Gastrointestinal symptoms during menstruation                                                                                  \<.001
   Yes                                                   42/312                   81/234                   3.40 (2.23-5.19)      
   No                                                    270/312                  153/234                  Reference             
  Urinary symptoms during menstruation                                                                                           \<.001
   Yes                                                   8/312                    24/234                   4.34 (1.91-9.85)      
   No                                                    304/312                  210/234                  Reference             
  Previous surgical diagnosis of endometriosis                                                                                   \<.001
   Yes                                                   7/246                    40/233                   7.07 (3.10-16.14)     
   No                                                    239/246                  193/233                  Reference             
  Previous hormonal treatment for endometriosis                                                                                  \<.001
   Yes                                                   4/263                    60/234                   22.32 (7.97-62.52)    
   No                                                    259/263                  174/234                  Reference             
  Associated diseases                                                                                                            .232
   Yes                                                   24/311                   12/234                   0.65 (0.32-1.32)      
   No                                                    287/311                  222/234                  Reference             
  Allergic rhinitis, asthma, eczema or anaphylaxis                                                                               .204
   Yes                                                   18/311                   8/234                    0.58 (0.25-1.35)      
   No                                                    293/311                  226/234                  Reference             
  Previous uterine surgery                                                                                                       .037
   Yes                                                   52/311                   56/234                   1.57 (1.03-2.39)      
   No                                                    259/311                  178/234                  Reference             
  Time since menarche (years)                            18.08 (5.45; n = 311)    19.16 (5.14; n = 234)    1.47 (1.06-2.03)      .020
  Menstrual cycle regularity                                                                                                     .017
   Always or usually regular                             284/311                  226/234                  Reference             
   Irregular                                             27/311                   8/234                    0.37 (0.17-0.84)      
  Tampon use during menstruation                                                                                                 .466
   Yes                                                   41/311                   36/234                   1.20 (0.74-1.94)      
   No                                                    270/311                  198/234                  Reference             
  Practices vaginal douching                                                                                                     .075
   Yes                                                   27/311                   11/234                   0.52 (0.25-1.07)      
   No                                                    284/311                  223/234                  Reference             
  Ovulatory disorders, amenorrhea or menorrhagia                                                                                 .466
   Yes                                                   28/311                   17/234                   0.79 (0.42-1.48)      
   No                                                    283/311                  217/234                  Reference             
  Combined oral contraceptive pill                                                                                               .922
   Currently or previously                               5/312                    4/234                    1.07 (0.28-4.02)      
   Never                                                 307/312                  230/234                  Reference             
  Progestin-only oral contraceptive                                                                                              .033
   Yes                                                   15/312                   3/234                    0.26 (0.07-0.90)      
   No                                                    297/312                  231/234                  Reference             
  Intrauterine device                                                                                                            .795
   Currently or previously                               39/312                   31/234                   1.07 (0.65-1.77)      
   Never                                                 273/312                  203/234                  Reference             
  Barrier contraception on a regular basis                                                                                       .601
   Yes                                                   173/312                  135/234                  1.10 (0.78-1.54)      
   No                                                    139/312                  99/234                   Reference             
  Prior pregnancy                                                                                                                .047
   Yes                                                   175/312                  151/234                  1.42 (1.00-2.02)      
   No                                                    137/312                  83/234                   Reference             
  Premature birth                                                                                                                .054
   Yes                                                   10/312                   16/234                   2.22 (0.99-4.98)      
   No                                                    302/312                  218/234                  Reference             
  Born from a twin pregnancy                                                                                                     .219
   Yes                                                   9/312                    3/234                    0.44 (0.12-1.63)      
   No                                                    303/312                  231/234                  Reference             
  Having been breastfed                                                                                                          .018
   Yes                                                   269/310                  218/234                  Reference             
   No                                                    41/310                   16/234                   0.48 (0.26-0.88)      
  Siblings                                                                                                                       .870
   Yes                                                   222/312                  168/234                  1.03 (0.71-1.50)      
   No                                                    90/312                   66/234                   Reference             
  Age of mother at birth                                 27.27 (4.55; n = 271)    26.73 (3.99; n = 222)    0.75 (0.49-1.13)      .170
  Family history of obesity                                                                                                      .471
   Yes                                                   13/312                   7/234                    0.71 (0.28-1.81)      
   No                                                    299/312                  227/234                  Reference             
  Family history of early menopause                                                                                              1.000
   Yes                                                   4/312                    3/234                    1.00 (0.22-4.51)      
   No                                                    308/312                  231/234                  Reference             
  Endometriosis in a first-degree relative                                                                                       .035
   Yes                                                   3/312                    9/234                    4.12 (1.10-15.39)     
   No                                                    309/312                  225/234                  Reference             
  Malignancy in a first-degree relative                                                                                          .565
   Yes                                                   24/312                   15/234                   0.82 (0.42-1.60)      
   No                                                    288/312                  219/234                  Reference             
  Malignancy in a second-degree relative                                                                                         .911
   Yes                                                   39/312                   30/234                   1.03 (0.62-1.71)      
   No                                                    273/312                  204/234                  Reference             
  Lives in a city or busy area                                                                                                   .099
   Yes                                                   259/312                  181/234                  Reference             
   No                                                    53/312                   53/234                   1.43 (0.94-2.19)      
  Lives or works in a smoky atmosphere                                                                                           .631
   Yes                                                   68/311                   55/233                   1.10 (0.74-1.65)      
   No                                                    243/311                  178/233                  Reference             
  Usually drinks filtered/bottled water                                                                                          .903
   Never or rarely                                       69/312                   55/234                   Reference             
   Sometimes                                             99/312                   75/234                   0.95 (0.60-1.51)      
   Often or always                                       144/312                  104/234                  0.91 (0.59-1.40)      
  Number of days exposed to sun for \>1 hour             135.4 (121.5; n = 292)   139.7 (123.2; n = 222)   1.00 (0.99-1.02)      .694
  Use of indoor tanning bed                                                                                                      .980
   Yes                                                   2/311                    0/233                    --                    
   No                                                    309/311                  233/233                  Reference             
  Use of thermal facilities                                                                                                      .526
   Yes                                                   75/311                   62/234                   1.13 (0.77-1.67)      
   No                                                    236/311                  172/234                  Reference             
  Employment status                                                                                                              .738
   Employed                                              239/310                  188/232                  Reference             
   Housewife                                             40/310                   26/232                   0.83 (0.49-1.40)      
   Retired                                               0/310                    1/232                    --                    
   Unemployed                                            8/310                    3/232                    0.48 (0.12-1.82)      
   Not working due to present health status              23/310                   14/232                   0.77 (0.39-1.54)      
  Salt added to cooking                                                                                                          .114
   Yes                                                   301/310                  232/234                  Reference             
   No                                                    9/310                    2/234                    0.29 (0.06-1.35)      
  Units of alcohol per week                              0.12 (0.51; n = 298)     0.30 (1.34; n = 229)     9.83 (1.02-95.06)     .048
  Regular exercise                                                                                                               .628
   Yes                                                   135/311                  106/233                  1.09 (0.77-1.53)      
   No                                                    176/311                  127/233                  Reference             
  Number of hours of sleep per night                                                                                             .339
   \>8 hours                                             61/312                   56/233                   1.34 (0.88-2.03)      
   6-8 hours                                             227/312                  156/233                  Reference             
   \<6 hours or does not sleep well                      24/312                   21/233                   1.27 (0.68-2.37)      
  Stress level                                                                                                                   .112
   Not at all stressed                                   16/312                   20/233                   Reference             
   Mild, moderate, marked, or extreme stress             296/312                  213/233                  0.58 (0.29-1.14)      
  Irritable or short-tempered                                                                                                    .612
   Never or rarely                                       74/312                   49/233                   Reference             
   Sometimes                                             151/312                  111/233                  1.11 (0.72-1.72)      
   Often or always                                       87/312                   73/233                   1.27 (0.79-2.04)      
  Lack of motivation to take part in social activities                                                                           .212
   Never                                                 30/311                   34/233                   Reference             
   Rarely or sometimes                                   225/311                  159/233                  0.62 (0.37-1.06)      
   Often or always                                       56/311                   40/233                   0.63 (0.33-1.19)      
  Difficulty controlling anxieties or worries                                                                                    .685
   Yes                                                   98/312                   77/233                   1.08 (0.75-1.55)      
   No                                                    214/312                  156/233                  Reference             
  Nonconsensual sexual contact                                                                                                   .872
   Yes                                                   6/288                    5/218                    1.10 (0.33-3.67)      
   No                                                    282/288                  213/218                  Reference             
  Health status                                                                                                                  .056
   Excellent, very good, or good                         154/312                  91/232                   Reference             
   Fair                                                  144/312                  126/232                  1.48 (1.04-2.11)      
   Poor                                                  14/312                   15/232                   1.81 (0.84-3.93)      

Abbreviations: BMI, body mass index; CI, confidence interval; DIE, deep infiltrating endometriosis; Non-EM, no endometriosis; OMA, endometrioma; OR, odds ratio; SD, standard deviation; SUP, superficial peritoneal endometriosis.

^a^ Odds ratio expressed for a 10-unit increment in age.

^b^ A union that lacks any publicly recognized bond.

Multivariable Analysis of Factors Associated With OMA and DIE {#section10-1933719118820469}
-------------------------------------------------------------

The following variables were entered into the multivariable analysis: addition of salt to cooking, premature birth, not having been breastfed, gastrointestinal symptoms during menstruation, health status, endometriosis in a first-degree relative, menstrual cycle regularity, living in a city or by a busy area, practicing vaginal douching, previous uterine surgery, progestin-only oral contraceptive pill, smoking status, stress level, previous hormonal treatment for endometriosis, infertility, and previous surgical diagnosis of endometriosis. The multivariable analysis identified the following factors as independently associated with OMA and DIE: not having been breastfed (OR = 0.33, 95% CI: 0.16-0.69), previous hormonal treatment for endometriosis (OR = 17.95, 95% CI: 5.92-54.43), gastrointestinal symptoms during menstruation (OR = 3.18, 95% CI: 1.90-5.31), not living in a city or by a busy area (OR = 2.14, 95% CI: 1.27-3.60), not having infertility (OR = 0.55, 95% CI: 0.34-0.87), previous surgical diagnosis of endometriosis (OR = 3.18, 95% CI: 1.90-5.31), regular menstrual cycles (OR = 0.36, 95% CI: 0.13-0.96), and not practicing vaginal douching (OR = 0.39, 95% CI: 0.16-0.97; [Table 3](#table3-1933719118820469){ref-type="table"}). Among the identified factors, the only one related to early-life exposure was not having been breastfed, and we subjected it to further robustness analysis to check whether it remained a significant factor when the OMA and DIE groups were considered separately instead of as one group.

###### 

Multivariable Analysis of the Factors Associated With OMA and DIE.^a^

![](10.1177_1933719118820469-table3)

  Characteristic                                  Non-EM + SUP   OMA + DIE   OR (95% CI)          *P*
  ----------------------------------------------- -------------- ----------- -------------------- --------
  Infertility                                                                                     .011
   Yes                                            80/238         59/233      0.55 (0.34-0.87)     
   No                                             158/238        174/233     Reference            
  Gastrointestinal symptoms during menstruation                                                   \<.001
   Yes                                            38/238         81/233      3.18 (1.90-5.31)     
   No                                             200/238        152/233     Reference            
  Previous surgical diagnosis of endometriosis                                                    .018
   Yes                                            7/238          40/233      3.06 (1.21-7.73)     
   No                                             231/238        193/233     Reference            
  Previous hormonal treatment for endometriosis                                                   \<.001
   Yes                                            4/238          60/233      17.95 (5.92-54.43)   
   No                                             234/238        173/233     Reference            
  Menstrual cycle regularity                                                                      .041
   Always or usually regular                      219/238        225/233     Reference            
   Irregular                                      19/238         8/233       0.36 (0.13-0.96)     
  Practices vaginal douching                                                                      .043
   Yes                                            21/238         11/233      0.39 (0.16-0.97)     
   No                                             217/238        222/233     Reference            
  Breastfed                                                                                       .003
   Yes                                            205/238        217/233     Reference            
   No                                             33/238         16/233      0.33 (0.16-0.69)     
  Lives in a city or busy area                                                                    .004
   Yes                                            202/238        181/233     Reference            
   No                                             36/238         52/233      2.14 (1.27-3.60)     

Abbreviations: CI, confidence interval; DIE, deep infiltrating endometriosis; Non-EM, no endometriosis; OMA, endometrioma; OR, odds ratio; SUP, superficial peritoneal endometriosis.

^a^ The Hosmer-Lemeshow goodness-of-fit test yielded a *P* value of .789, indicating a good fit.

Further Prespecified Subgroup Analysis on Not Having Been Breastfed {#section11-1933719118820469}
-------------------------------------------------------------------

Further subgroup multivariable analysis confirmed not having been breastfed as a protective factor for DIE, when compared with non-EM (OR = 0.13, 95% CI: 0.02-0.88), and with OMA + SUP (OR = 0.19, 95% CI: 0.04-0.85). Nevertheless, the univariable results did not show that not having been breastfed was a protective factor for OMA, when compared with non-EM (OR = 0.66, 95% CI: 0.32-1.36), and with SUP (OR = 0.63, 95% CI: 0.31-1.30).

Discussion {#section12-1933719118820469}
==========

To the best of our knowledge, this subgroup analysis of the population of Chinese women from the FEELING study is the first multicenter case--control study to explore early-life factors potentially related to different phenotypes of endometriosis. The main finding of the present study was that having been breastfed was associated with OMA and DIE, as were previous hormonal treatment for endometriosis, gastrointestinal symptoms during menstruation, not living in a city or by a busy area, not having infertility, previous surgical diagnosis of endometriosis, regular menstrual cycles, and not practicing vaginal douching. As not having been breastfed was identified as a protective factor in the initial Chinese substudy analysis, we performed further subgroup robustness analyses, and the results indicated that this factor may only be a protective factor against DIE.

Only a small number of previous studies have reported the relationship between history of having been breastfed and endometriosis in adult life. The FEELING study, on which the present analysis is based, did not find a significant association of having been breastfed with OMA and/or DIE when all participants from China, Russia, and France were analyzed together.^[@bibr31-1933719118820469]^ The subgroup analysis suggested that not having been breastfed might be protective against DIE in participants from China but not from France or Russia, raising the intriguing possibility of regional differences in the impact of this factor.^[@bibr31-1933719118820469]^ Indeed, the FEELING study noted several intercountry differences highlighting the complex and multifactorial origins of endometriotic disease.^[@bibr31-1933719118820469]^

Our observation that not having been breastfed may be a protective early-life factor against DIE in Chinese women is not in agreement with previous studies in women of other ethnicities. Vannuccini et al investigated the influence of several intrauterine and early neonatal exposures and found that formula feeding and prematurity were risk factors of developing endometriosis in adult life in women from Italy.^[@bibr34-1933719118820469]^ Similarly, a study in Japan determined that breast-fed infants have a lower incidence of endometriosis in adult life.^[@bibr35-1933719118820469]^ In contrast, another study found that perinatal factors, including breastfeeding, might not play an important role in the pathogenesis of endometriosis.^[@bibr36-1933719118820469]^ The reasons for the seemingly inconsistency between our results and those of other investigations remain unknown, but there are several possibilities. One plausible explanation is that, in China, breastfed infants might be exposed to higher levels of environmental toxicants (such as dioxins and related compounds) that are present in breast milk and contribute to the pathogenesis of endometriosis.^[@bibr30-1933719118820469],[@bibr37-1933719118820469],[@bibr38-1933719118820469]^ These toxicants have been suggested to promote endometriosis development through various mechanisms, including epigenetic mechanisms that alter the expression of hormone receptors.^[@bibr30-1933719118820469],[@bibr37-1933719118820469][@bibr38-1933719118820469][@bibr39-1933719118820469]--[@bibr40-1933719118820469]^ Unfortunately, being a first child or not was not collected as a variable and could not be analyzed in terms of higher exposure to toxicants. Another possibility is that formula milk used in China may differ from that used in the other countries where the previous studies were conducted. Two studies (in the United States and Europe) reported that having been fed with soy formula milk increased the risk of endometriosis, and it was suggested that this effect of formula milk might involve an augmentation in the levels of estrogen and testosterone in the infant.^[@bibr34-1933719118820469],[@bibr41-1933719118820469]^ Thus, it is not inconceivable that lower hormone levels in formula milk in China may have negated and even reversed any effect of formula milk on endometriosis risk. A third potential reason is that the present study analyzed different phenotypes separately and found the protecting effect only for DIE, while all previous studies considered different phenotypes of endometriosis indifferently as a homogenous disease. The origins and pathogeneses of the various endometriosis phenotypes likely differ, and many experts do not consider SUP to represent true endometriotic disease.^[@bibr16-1933719118820469],[@bibr32-1933719118820469],[@bibr33-1933719118820469]^ Furthermore, studies also indicate that the potential causes for the differences between OMA and DIE might vary in several aspects such as epithelial--mesenchymal transition, fibroblast-to-myofibroblast transdifferentiation and smooth muscle metaplasia.^[@bibr42-1933719118820469]^ This variation in methodology may thus have contributed to the seemingly inconsistency between this study and previous investigations. In addition, it cannot be excluded that selection bias in our study may have influenced our findings, since most women in China prefer to breastfeed their infants, and hence most participants in this study were breastfed.^[@bibr43-1933719118820469],[@bibr44-1933719118820469]^ Further research is needed to validate the association found and establish the underlying mechanisms of the apparent protective effect of not having been breastfed against DIE in Chinese women. Since professional women and those with higher education tend to breastfeed their infants less in China, thus have comparatively reduced mother--infant contact, this can be one of the potential directions to be explored in future studies.

It is perhaps not surprising that previous surgical diagnosis of endometriosis or previous hormonal treatment of endometriosis was associated with OMA and DIE, as more severe or deeply infiltrating disease (OMA and DIE) would be more likely to have already been clinically detected and treated than superficial disease (ie, SUP), explaining why a higher proportion of participants with OMA and DIE received a previous diagnosis or hormonal therapy than participants with SUP. Furthermore, our observation that the severity of gastrointestinal symptoms during menstruation was associated with OMA, and DIE is consistent with previous studies showing an association between advanced endometriosis and dysmenorrhea.^[@bibr45-1933719118820469],[@bibr46-1933719118820469]^ In the FEELING study, the associations of OMA and DIE with previous surgical diagnosis of endometriosis and previous hormonal treatment of endometriosis were found for participants from all 3 countries, while the association with severity of gastrointestinal symptoms during menstruation was observed in participants from both China and Russia.^[@bibr31-1933719118820469]^

Endometriosis is known to be associated with infertility, although the underlying mechanisms remain unclear.^[@bibr47-1933719118820469]^ The observation in the present study that infertility was inversely associated with OMA and DIE may therefore seem somewhat unexpected. However, as noted in the FEELING study,^[@bibr31-1933719118820469]^ infertility may have been the main indication for surgery among the non-EM/SUP cases, explaining our finding.

It has been suggested that the prevalence of endometriosis should be low in remote rural settings that are characterized by high fertility rate, frequent teenage pregnancy, and protracted breastfeeding, all of which reduce the total number of menstrual cycles.^[@bibr36-1933719118820469],[@bibr48-1933719118820469]^ However, in the current study, living in a city or by a busy area appeared to be protective against OMA and DIE. In the FEELING study, such an association was not observed in participants from France or Russia.^[@bibr31-1933719118820469]^ Similarly, although the present study revealed a possible protective effect of vaginal douching against endometriosis, no effect was observed for participants from France or Russia in the FEELING study^[@bibr31-1933719118820469]^ or for women in the United States in another case--control study.^[@bibr49-1933719118820469]^ The reasons for these apparent inconsistencies are unknown and merit further consideration in future research.

This study has some limitations. The sample size in this study was rather small; hence, additional data from a larger population are needed to confirm and extend our observations. As mentioned above, most participants in this study were breastfed, which may have introduced a degree of selection bias. In addition, there may have been a bias against enrollment of women in less developed areas due to a decreased willingness to undergo medical investigations for diagnosis of the disease (eg, due to economic factors) and/or a reduced diagnostic efficiency in rural medical centers (which have less medical expertise in this field). Thus, the role of environmental factors may not have been fully explored. Further prospective studies are required to confirm the conclusion of the current research.

In conclusion, not having been breastfed was found to be a potentially protective early-life factor against DIE in Chinese women. Further studies are warranted to confirm this finding from an observational study, and to explore the possible underlying mechanisms.
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